We all make mistakes, and some cost more than others. It seems that your brain has a special compartment set aside to absorb these moments.
We all make mistakes, and some cost more than others. It seems that your brain has a special compartment set aside to absorb these moments.
Using functional MRI, Dr. Stephan Taylor, an associate professor of psychiatry at the University of Michigan Medical School, and colleagues found that the rostral anterior cingulate cortex, or rACC, lights up when a person realizes he or she has made an error that carries consequences, such as losing money.
By contrast, the same area of the brain is virtually dormant when the mistake doesn't carry a penalty or when a correct action carries a reward.
Interestingly, obsessive-compulsive disorder patients had previously shown a more active rACC response compared with controls, but to a no-penalty error. Researchers want to use the same experiment with OCD patients to help pinpoint which of their brain circuits have gone awry (J Neurosci Apr 2006; 26:4063-4070).
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.
2 Clarke Drive
Cranbury, NJ 08512